4.4 Article

Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance

期刊

JOURNAL OF INHERITED METABOLIC DISEASE
卷 33, 期 6, 页码 715-725

出版社

WILEY
DOI: 10.1007/s10545-010-9192-5

关键词

-

资金

  1. National Institutes of Health [DK-065089]

向作者/读者索取更多资源

Hereditary fructose intolerance (HFI) is a potentially fatal inherited metabolic disease caused by a deficiency of aldolase B activity in the liver and kidney. Over 40 disease-causing mutations are known in the protein-coding region of ALDOB. Mutations upstream of the protein-coding portion of ALDOB are reported here for the first time. DNA sequence analysis of 61 HFI patients revealed single base mutations in the promoter, intronic enhancer, and the first exon, which is entirely untranslated. One mutation, g.-132G > A, is located within the promoter at an evolutionarily conserved nucleotide within a transcription factor-binding site. A second mutation, IVS1+1G > C, is at the donor splice site of the first exon. In vitro electrophoretic mobility shift assays show a decrease in nuclear extract-protein binding at the g.-132G > A mutant site. The promoter mutation results in decreased transcription using luciferase reporter plasmids. Analysis of cDNA from cells transfected with plasmids harboring the IVS1+1G > C mutation results in aberrant splicing leading to complete retention of the first intron (similar to 5 kb). The IVS1+1G > C splicing mutation results in loss of luciferase activity from a reporter plasmid. These novel mutations in ALDOB represent 2% of alleles in American HFI patients, with IVS1+1G > C representing a significantly higher allele frequency (6%) among HFI patients of Hispanic and African-American ethnicity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据